<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1283">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04517123</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00249663</org_study_id>
    <nct_id>NCT04517123</nct_id>
  </id_info>
  <brief_title>Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The &quot;PRONE&quot; Study</brief_title>
  <acronym>PRONE</acronym>
  <official_title>Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The &quot;PRONE&quot; Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of North Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Smith &amp; Nephew, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nox Medical Iceland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this study is to determine whether a positional maneuver (e.g.,
      prone positioning) decreases the need for escalation of respiratory-related care in patients
      with coronavirus (COVID-19) pneumonia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As the initial outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
      and the disease it causes, coronavirus disease 2019 (COVID-19) has spread beyond Wuhan, China
      it has become a pandemic affecting over 178 countries. Of patients admitted to the ICU,
      upwards of 85% developed the acute respiratory distress syndrome (ARDS) and most if not all
      required mechanical ventilation. The beneficial effects of prone positioning for ARDS have
      been well described. Coupling the reported benefits of prone positioning in COVID-19
      associated ARDS patients with the known beneficial effects of early prone-positioning in the
      treatment of ARDS, it is not surprising that many hospital systems are advocating prone
      positioning for treatment of ARDS in patients with COVID-19. However, as the pandemic
      continues to progress in the United States and the number of new cases grows as new clusters
      emerge, the possibility of 'rationing' ventilators becomes more real. Therefore, therapies
      that prevent the need for mechanical ventilation are desperately needed. Given the distinct
      benefit that patients with COVID-19 have with prone positioning, the overarching hypothesis
      of this trial is that patients with high risk for respiratory failure may also benefit from
      prone positioning.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of an escalation in respiratory related care (yes vs no)</measure>
    <time_frame>During hospitalization, up to 30 days</time_frame>
    <description>Participants will be assessed for the occurrence of an escalation in respiratory related care (Yes or No). Escalation in respiratory related care is clinically defined as any of the following:
intubation
any increase in flow of supplemental oxygen
transition to high flow nasal cannula
increase in fraction of inspired oxygen
transfer from a lower to a higher level acuity of care (e.g. medical floor to intermediate care unit (IMC) or intensive care unit (ICU); IMC to ICU).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygen Saturation</measure>
    <time_frame>Over a consecutive 24-hour period after randomization</time_frame>
    <description>Oxygen Saturation measured in percent oxygen over a 24-hour period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Effort as assessed by Respiratory Rate</measure>
    <time_frame>Over a consecutive 24-hour period after randomization</time_frame>
    <description>Respiratory effort will be assessed using the respiratory rate (in breaths per minute) over a 24-hour period.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Covid19</condition>
  <condition>Pneumonia, Viral</condition>
  <arm_group>
    <arm_group_label>Control - Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual Care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention - Prone Positioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prone Positioning</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prone Positioning</intervention_name>
    <description>Prone Positioning</description>
    <arm_group_label>Intervention - Prone Positioning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  COVID-19 positive by nasopharyngeal swab or serostatus

          -  Use of supplemental oxygen OR respiratory rate ≥ 20

        Exclusion Criteria:

          -  BMI ≥ 45 kg/m2

          -  Pregnancy

          -  Chest tube placement

          -  Hemodynamic instability with mean arterial pressure &lt; 60 mmHg

          -  Thoracic or abdominal wounds

          -  Chest wall deformities

          -  Vertebral column deformities that would preclude prone positioning

          -  Facial trauma or surgery in the last 30 days

          -  Established diagnosis of interstitial lung disease

          -  Prior single or double lung transplant

          -  Surgery for spine, femur, or pelvis in the last 3 months

          -  Thoracic or cardiac surgery in the last 30 days

          -  Pacemaker placement last 7 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naresh Punjabi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahendra Damarla</last_name>
    <phone>410-550-0545</phone>
    <email>mdamarl1@jhmi.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Johns Hopkins Univeristy</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahendra Damarla, MD</last_name>
      <email>mdamarl1@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27514</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaspn Mock, MD, PhD</last_name>
      <email>jason_mock@med.unc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eugene Friedman, MD, PhD</last_name>
      <email>eugene.friedman@duke.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 14, 2020</study_first_submitted>
  <study_first_submitted_qc>August 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2020</study_first_posted>
  <last_update_submitted>September 23, 2020</last_update_submitted>
  <last_update_submitted_qc>September 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>covid19</keyword>
  <keyword>pneumonia</keyword>
  <keyword>prone positioning</keyword>
  <keyword>COVID</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia, Viral</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

